UK markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
169.78+12.72 (+8.10%)
As of 02:55PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
23,302,900
18,976,700
482,325
108,589
127,575
Cost of revenue
4,991,300
3,860,700
704,362
243,827
156,730
Gross profit
18,311,600
15,116,000
-222,037
-135,238
-29,155
Operating expenses
Research development
-
-
2,033
226,466
143,040
Selling general and administrative
386,400
328,900
101,424
43,410
27,090
Total operating expenses
322,000
200,100
-132,618
46,280
24,698
Operating income or loss
17,989,600
14,915,900
-89,419
-181,518
-53,853
Interest expense
8,800
5,400
2,003
1,718
1,721
Total other income/expenses net
461,700
156,300
-52,896
2,341
5,966
Income before tax
18,422,200
15,046,400
-145,802
-179,440
-47,662
Income tax expense
5,559,000
4,753,900
-161,000
-268
600
Income from continuing operations
12,863,200
10,292,500
15,198
-179,172
-48,262
Net income
12,863,200
10,292,500
15,198
-179,056
-48,019
Net income available to common shareholders
12,863,200
10,292,500
15,198
-179,056
-48,019
Basic EPS
-
-
0.06
-0.85
-0.21
Diluted EPS
-
-
0.06
-0.85
-0.21
Basic average shares
-
-
253,300
211,499
226,262
Diluted average shares
-
-
253,300
211,499
226,262
EBITDA
-
15,127,000
-105,055
-143,826
-23,957